Twist Bioscience Reports Record FY2026 Revenue
Twist Bioscience recorded revenue of $459.4 million in FY2026, up 22% YoY, and issued fiscal 2027 guidance of $550M-$560M. The announcement highlights continued growth and an improvement in gross margins.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed